Abstract
Background and study aim: Ulcerative colitis (UC) and Crohn's disease (CD) are the common forms of inflammatory bowel disease (IBD). The etiology and pathogenesis are not fully understood yet. Many studies have been focused on adipokines in the pathogenesis of IBD. IBD is associated with alteration in fat distribution and development of white adipose tissue (WAT) hypertrophy in the mesentery. Most of adepokines are formed in WAT or in immune cells play an important role in IBD manifestations. The aim of this study was to evaluate the levels of resistin and visfatin in IBD patients before and after treatment. Patients and methods: 40 patients with IBD (15 patients with CD and 25 patients with UC) attended to Tropical Medicine and Internal Medicine Departments; Zagazig University Hospitals from March 2012 till December 2013 were included in this study. Serum levels of resistin and visfatin were measured before treatment and 3 months after treatment. Results : The mean serum levels of resistin in Crohn's disease ranged from 12.2+2 ng/ml to 9.0 + 4.0 (P= 0.1) and the mean serum levels of visfatin in Crohn's disease ranged from 5.6+4.6 ng/ml to 3.4+4.1 ng/ml (P= 0.04) before and after treatment respectively, and the mean serum levels of resistin in ulcerative colitis ranged from 11.2+2 ng/ml to 7.5+ 3.1 ng/ml (P= 0.039) and the mean serum levels of visfatin in ulcerative colitis ranged from 3.7+1.2 to 2.5+1.1 ng/ml (P= 0.004) before and after treatment respectively. Conclusion : The serum levels of resistin and visfatin decreased significantly after treatment induction for IBD so can be used as a marker for treatment success
Highlights
Inflammatory bowed disease (IBD) is inflammatory condition of small intestine and the colon
Medicine and Internal Medicine treatment induction for IBD, so can be Departments; Zagazig University used as a marker for treatment success
Most of adipokines are formed in white adipose tissue (WAT) or in immune cells play an important role in IBD pathogenesis [12,13].Resistin is one of the cysteinerich proteins family, it was described as adipocyte-derived mediator of hepatic insulin resistance [14], it is produced by mononuclear cells [15], and minimal amount is produced by visceral adipose tissue [16]
Summary
Inflammatory bowed disease (IBD) is inflammatory condition of small intestine and the colon. Serum the common forms of inflammatory levels of resistin and visfatin were bowel disease (IBD). Many studies have been focused on Results: The mean serum levels of adipokines in the pathogenesis of IBD. IBD is associated with alteration in fat 12.2+2 ng/ml to 9.0 + 4.0 (P= 0.1) and the distribution and development of white mean serum levels of visfatin in Crohn's adipose tissue (WAT) hypertrophy in the disease ranged from 5.6+4.6 ng/ml to mesentery. Most of adepokines are 3.4+4.1 ng/ml (P= 0.04) before and after formed in WAT or in immune cells and treatment respectively, and the mean serum play an important role in IBD levels of resistin in ulcerative colitis ranged manifestations. The aim of this study was from 11.2+2 ng/ml to 7.5+ 3.1 ng/ml
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Afro-Egyptian Journal of Infectious and Endemic Diseases
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
